Fresenius Medical Care Sees U.S. Plans for Kidney Disease as Positive
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
We are actively monitoring the novel coronavirus (COVID-19) pandemic. Learn About the steps that we are taking to protect our patients, employees, physicians, and partners. If you are a patient with questions or concerns, please find additional information at FreseniusKidneyCare.com and AzuraVascularCare.com
As a long-time leader in the development and successful application of value based models of care for chronic needs populations, Fresenius Health Partners focuses on quality to help drive improved health outcomes while reducing the total cost of care.
We place patients at the center of an integrated care team. As part of one of the nation's largest providers of dialysis services, we are uniquely positioned to leverage our advanced analytics—using both clinical data and in-person interactions—to identify health risks and create informed individualized care plans.
Our strategy is centered around assuming responsibility for the cost, quality, and outcomes for our patients' care. FHP brings together three components critical to the success of a value based payment model:
Combining an evidenced-based approach with an in-depth knowledge of the patient helps to create personalized treatment plans that effectively achieve our program goals. Our expertise in improving health outcomes is key to reducing the financial challenges of chronic diseases such as ESRD for both patients and payors throughout the United States .